Royal Bank Of Canada reissued their neutral rating on shares of Reckitt Benckiser Group (LON:RKT – Free Report) in a research note issued to investors on Friday, Marketbeat reports. The brokerage currently has a GBX 6,200 price target on the stock.
RKT has been the subject of several other reports. Berenberg Bank cut their price objective on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research report on Friday, April 24th. Deutsche Bank Aktiengesellschaft dropped their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research report on Tuesday, April 28th. Jefferies Financial Group reissued a “hold” rating and issued a GBX 5,600 price target on shares of Reckitt Benckiser Group in a report on Tuesday. Finally, Citigroup reduced their price objective on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Three investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of GBX 6,204.29.
Check Out Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Up 0.4%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its earnings results on Thursday, March 5th. The company reported £122.58 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 25.23% and a return on equity of 38.45%. On average, equities research analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Reckitt Benckiser Group news, insider Kris Licht sold 5,435 shares of Reckitt Benckiser Group stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of GBX 4,753, for a total value of £258,325.55. 0.44% of the stock is currently owned by corporate insiders.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
